|
Primary outcome
|
|
Mean DD symptom severity scores
|
PHQ-9 [41]
|
√
| |
|
Secondary outcomes
| | | |
|
Mean DD symptom severity scores
|
PHQ-9 [41]
| |
√
|
|
Remission (proportion with PHQ-9 scores < 5)
|
PHQ-9 [41]
|
√
|
√
|
|
Mean generalised anxiety disorder (GAD) severity scores
|
GAD-7 [47]
|
√
|
√
|
|
Quality adjusted life years (QALYs)
|
EQ-5D-5 L [48]
|
√
|
√
|
|
Days out of work (over 3 months)
|
Patient cost questionnaire
|
√
|
√
|
|
Functional impairment and welfare
|
OxCAP-MH [49]
|
√
|
√
|
|
Patients’ satisfaction with depression care
|
Modified Patient Satisfaction Survey by Ede et al. [50]
|
√
| |
|
Carers’ perceptions and satisfaction levels with integration efforts at HIV clinic
|
Modified Staff Survey by Ede et al. [50]
|
√
| |
|
Proportion with virological failure (a proxy measure of adherence; defined as a viral load of 400 copies/ml or more)
|
HIV viral load (copies/ml)
| |
√
|
|
Reported adherence to ART (proportion of participants who have missed at least one dose of ART in the past three days compared against the baseline value)
|
Assessed by means of the question, ‘Have you missed taking ART in the last 3 days?’ Possible responses 1 = Yes, 2 = No
|
√
|
√
|
